AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • November 15th, 2016 • BeyondSpring Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 15th, 2016 Company Industry JurisdictionThis Amended and Restated Employment Agreement (“Agreement”) is entered into on November 10, 2016 (the “Effective Date”) by and between BeyondSpring Pharmaceuticals, Inc. (“Company”) and Dr. Lan Huang (“Employee”) (collectively, the “Parties”).
First Amendment to Consulting AgreementConsulting Agreement • November 15th, 2016 • BeyondSpring Inc. • Pharmaceutical preparations • Maryland
Contract Type FiledNovember 15th, 2016 Company Industry JurisdictionThis First Amendment (“Amendment”) to the consulting Agreements signed on June 18, 2013, and is effective as of March 30, 2014 (the “Amendment Date”), and is entered into by and among:
TERMINATION AGREEMENT To ASSET PURCHASE AGREEMENTTermination Agreement • November 15th, 2016 • BeyondSpring Inc. • Pharmaceutical preparations • California
Contract Type FiledNovember 15th, 2016 Company Industry JurisdictionThis Termination Agreement to Asset Purchase Agreement (this "Agreement") is made and entered into as of February 2, 2015 (the "Effective Date") by and among BeyondSpring Inc., a Cayman Islands exempted company (the "Company"), Dalian Wanchun Biotechnology Co., Ltd. (hereinafter called "Wanchun") and Nereus Pharmaceuticals, Inc. (hereinafter called "Nereus"). In the event that the Company's IPO (as defined below) is not consummated within three (3) years following the Effective Date, the provisions of this Agreement shall not take effect. Each of the Company, Wanchun and Nereus is referred to herein individually as a "party" and collectively as the "parties".
Second Amendment to Consulting AgreementConsulting Agreement • November 15th, 2016 • BeyondSpring Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 15th, 2016 Company Industry JurisdictionThis Second Amendment (“Amendment”)to the consulting Agreements signed on June 18, 2013, and is effective as of June 1, 2015 (the “Amendment Date’). Because three way agreement was signed on March 30, 2014 and stated that BeyondSpring Pharmaceuticals, Inc. is taking over full responsibility and rights, so this agreement is only entered into by and among:
FORM OF INDEMNIFICATION AGREEMENTForm of Indemnification Agreement • November 15th, 2016 • BeyondSpring Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 15th, 2016 Company Industry JurisdictionAGREEMENT, effective as of , 2016, between BeyondSpring Inc., an exempted company incorporated in the Cayman Islands (the “Company”), and (the “Indemnitee”).